Lineage

We don’t have lineage among our bona fides?

Lineage is a product of continuity, and continuity is a product of evolution. Lineage has history, pedigree, familiarity, assurance. It reinforces our mental model of how good things happen and work. Because we like what we know and we know what we like, usually.

Innovation is a product of disruption, and disruption is a product of revolution. Innovation lacks history, pedigree, familiarity and assurance. It’s risky and uncomfortable. It may satisfy needs, but it takes a lot of getting used to and learning to trust. We usually don’t like what we don’t already know.

I hold these truths to be self-evident, but like most truths of that sort, they’re fraught with tension. That’s because people typically want to have their cake and eat it. They want lineage and innovation at the same time though the two may be diametrically opposed.

If you have attained lineage or you value and reward it, you probably don’t do innovation. You are less interested in the new than the known. Clayton Christensen coined the term “sustaining innovation” in order to connect the opposites — to argue that some innovators make incremental rather than transformational improvements, but that’s a mare’s nest. Making something better is a process of extending its lineage; it’s not an organizing principle of innovation.

The people who want to have their cake and eat it, those are individuals like ourselves, but also organizations such as employers and federal agencies like the National Science Foundation (“Where Discoveries Begin”) and the National Institutes of Health (“Turning Discovery Into Health”). Those agencies are much on my mind at present, because I’m sending SBIR (“America’s Seed Fund”) proposals to each.

The charter of SBIR is to promote innovation in part by selecting for lineage. That’s why most SBIR funds are given to nicely situated academic teams. Wait, let me clarify. SBIR funds are for corporate entrepreneurial teams, but in reality most of them are led and staffed by academic stakeholders who want to commercialize their previously funded academic research. Such stakeholders provide a project with lineage whereas scrappy inventors have only their wit and passion to recommend them, usually.

Unless memory fails me, as a former academician I’m pretty sure that college professors are generally risk averse. They are conservative, self-centered, they don’t like to put skin in the game, in fact they don’t like playing games with their career but prefer the certainties of job security, organizational hierarchy and the comforting sameness of job responsibilities that change only a little from season to season. The ubiquitous tenure system ensures that innovators are largely excluded from academia because they are disruptive.

That is why SBIR requirements for both lineage and innovation are an unacknowledged oxymoron. Unacknowledged because both are explicitly and unapologetically written into NSF solicitations and NIH funding opportunity announcements.

The best way to qualify for SBIR with these agencies is to derisk a project by summoning lineage as evidence that it’s a sure bet. And yet the best way to qualify for SBIR is to explain that the project is so risky that private investors won’t touch it with a ten-foot pole; therefore taxpayer money should finance it.

Humaginarium is one of those scrappy inventors born of a garage rather than an ivory tower. We have an innovation that is damned risky, and we don’t have lineage among our bona fides. What would you do in our place?

Well, we can’t become less innovative. Innovation is what makes our project meaningful and fun. And we can’t borrow lineage, can we?

Actually we can. Because the technologies we are bringing together have been developing for decades, in many cases with government funding, only not for our purposes. System dynamics, computer modeling of health, bioinformatics, biochemical engineering, predictive simulation, adaptive experiential learning, instructional technology. These are the cross threads of our invention, forming a new fabric of impact and consequence.

Precisely what consequence I can’t reveal here, not because it’s a secret but because I’m out of space. For now, suffice it to say that pretty soon you’re going to love what you don’t already know. That goes double for people with chronic illness.

A griffin of classical antiquity combining the eagle (innovation) and lion (lineage) into a mythic animal that embodies an impossible ideal. (Image courtesy of Pixabay.)

Green Light Redux

Two federal agencies have invited us to request SBIR Phase 1 funding.

I’m taking a break from game design this week to talk about progress on another front.

Back on April 10, I announced that the National Science Foundation approved Humaginarium’s Project Pitch. Today I’m announcing that the National Institute of Diabetes and Digestive and Kidney Diseases has approved our Specific Aims. Two US federal agencies have thus invited Humaginarium to apply in 2019 for substantial, non-dilutive, SBIR Phase 1 funding. In my opinion, that’s cool!

Specific Aims is a single page argument that our groundbreaking idea for biomedical innovation is a good fit for NIH support; and that it’s a good candidate for commercialization. I dubbed the idea Metabolic Genii.

In popular culture, a genie is Robin Williams magically springing from a bottle to make jokes and grant wishes. I’m fine with that; it fits our brand well enough, but the word genie is actually more meaningful. It’s a variant of genius, and a genius (plural: genii) is an attendant spirit: a force that influences actors for better or worse.

Metabolic genii are digital affordances that empower folks who have or risk developing metabolic disorders. The genii enable them to inquire what’s up with their bodies and gain a bit more control over their medical outcomes.

Like any genius worthy of that moniker, metabolic genii are extremely creative. Ours are creative like scientists rather than sorcerers. They intelligently pan for the personal gold in every individual they meet, ultimately enabling users to feel a little like Aladdin, with wishes that now make a lot more sense and eventually may come true.

The terminal objective of our Specific Aims is a set of six precise, repeatable techniques that reliably convert basic health literacy (acquired in a separate project) into resolute behavior. These six techniques are drawn from a social science palette that includes situational awareness, choice architecture, scenario planning, nudge theory, decision science, and reinforcement theory of motivation. According to my reading of research literature, these powerful and accessible affordances have never been synced to produce sustainable medical outcomes. We’re about to sync them in order to discover what happens next.

What do we expect to happen next? Empowerment. Users will demonstrate their ability and desire to make evidence-based decisions about illness and wellness; and furthermore make those decisions as sticky as flypaper. Sound easy? Sorry, it’s never been done before. That may be why health education mostly doesn’t work. At all.

Who is going to benefit from this project? Of course Humaginarium and its investors will benefit, but more importantly 60% of the adult population stands to benefit. That is the proportion who already have a poorly controlled chronic illness (the numbers are increasing). That’s also the proportion who play video games, the medium we are using to generate basic health literacy (and yes, those numbers are increasing too).

What will our R&D be like? It begins with a re-review of secondary research that bears on our terminal objective. From there it takes the form of agile discovery. We are not going to think this problem to death. Instead we shall design activities that a large number of experts and ordinary consumers can experience and comment with feedback. Each of these activities generates data that indicate efficacy and flow into other parts of the Metabolic Genii system.

Our Phase 1 research and development yields proof-of-concept of this system; and verifies its theoretical efficacy. If results are encouraging, we will migrate our hardening techniques into a Phase 2 design-build-test-deploy project. At that point, our world begins to resemble an oyster.

Metabolic Genii and it’s counterpart Diabetes Agonistes are now as two horses pulling a chariot named Humaginarium. Our chariot isn’t racing against competitors; there is none working at our level. We’re racing against time. We want to stymie metabolic disorders and other chronic illnesses as quickly and as soon as possible.

Click here to read the Specific Aims.

Green Light

We’re not going to leave the long and winding path, but SBIR may strengthen and speed our steps.

The National Science Foundation has given Humaginarium a green light to apply for substantial, non-dilutive, SBIR funding. The light came on right after I submitted my Project Pitch, a required first step that gauges whether Humaginarium can “meet the program’s objectives to support innovative technologies that show promise of commercial and/or societal impact and involve a level of technical risk.

The Humaginarium project seemed like a good fit way back in 2010 when I first looked into SBIR. That’s when I began ideation for this venture, years before founding it. I guess this illustrates how serendipitously I approach even things that are important to me, and how I tend to follow long and winding paths with a compass but not a map. Taking me forever!

The manifold innovative technologies I pitched to NSF include computer models of physiology, high-fidelity time-based simulations of morbidity at scale, state-of-the-art medical CGI, cloud-built and cloud-based entertainment that streams to screens everywhere. My pitch is not about inventing these incredible emerging technologies, but rather adapting them (for the first time) to the direct use and benefit of regular folks.

I pitched my belief that the Humaginarium project will have commercial and societal impact. As commerce it operates in the nexus between entertainment, health, and education: three large, fast-changing and fast-growing industries. It caters to strongly-felt consumer needs at the center of each industry – but in this unique case all at the same time, with the same products that we rapidly make and the same business processes that are noncapital intensive. As a social enterprise, Humaginarium promotes health literacy and health equity not for a few who can afford it, but for everybody who chooses to use it. If activists are leading us to a brave new world where health is a right and not a privilege, Humaginarium may become one of the enabling technologies of that world.

The level of technical risk in the Humaginarium project is pretty high. I say the work can be done, but at the same time acknowledge that it’s never been done before. I speak with the voice of a world I’ve imagined, that doesn’t yet exist: one that will deliberately avoid an apocalypse in health care by empowering self-care. I promise to make health science coherent and beautiful and playful and useful to folks who currently know almost nothing about it; and who typically don’t want to know anything about it (until it’s too late). This is truly a moonshot, one that enables “one giant leap” for every individual who takes a ticket.

In order to mitigate this crazy level of risk, I pitched a series of Phase 1 experiments that may define the most promising way forward. Not only to design, build and test an effective solution, but also to commercialize it. I say mitigate, not eliminate risk, because the Humaginarium project is a lion that doesn’t wear a leash. We won’t abandon the long and winding path because that’s where know-how and value are captured. Still, SBIR can speed and mightily strengthen our steps. The green light thrills me like a call to arms on the White Mountains.

Click here to read the Project Pitch.

Scientific Entertainment. Variation on Academic Study, by William Mulready